Oncolytic Virus Therapy Market Share 2022: Global Trends, Key Players, Industry Analysis Report to 2028

The Oncolytic Virus Therapy Market size is expected to grow at an annual average of 25% during 2021-2027. Oncolytic virus therapeutics is an overlapping field of biomedical research with similar therapeutic goals that target DNA or RNA inside or outside the body. These therapies aim to modify genetic material to treat disease. Oncolytic virus therapy is a form of gene therapy that uses natural substances (viruses) to find and destroy malignant cells. Oncolytic virus therapy is “a novel approach to treat, treat, or ultimately prevent disease by altering gene expression in a person”. Oncolytic virus therapy is a form of gene therapy that uses natural substances (viruses) to find and destroy malignant cells.

The following segmentation are covered in this report:

By End User

• Hospitals
• Specialty Clinics
• Cancer Research Institutes

By Virus Type

• Oncolytic Wild Type Viruses
• Genetically Engineered Oncolytic Viruses

Company Profile

• BioVex, Inc. (Amgen, Inc.)
• Cold Genesys, Inc. 
• DNAtrix Therapeutics 
• Genelux Corporation 
• Lokon Pharma AB 
• Oncolytics Biotech, Inc. 
• ORYX GmbH & Co. KG 
• PsiOxus Therapeutics 
• SillaJen, Inc.
• Sorrento Therapeutics,

Scope of the report

The research study analyses the Oncolytic Virus Therapy Market industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent developments

• Market overview and growth analysis
• Import and export overview
• Volume analysis
• Current market trends and future outlook
• Market opportunistic and attractive investment segment

Geographic coverage

• North america market size and/or volume
• Latin america market size and/or volume
• Europe market size and/or volume
• Asia-pacific market size and/or volume
• Rest of the world market size and/or volume

Key Questions Answered by Oncolytic Virus Therapy Market Report

• What was the Oncolytic Virus Therapy Market size in 2019 and 2020; what are the estimated growth trends and market forecast (2021-2027)
• What will be the CAGR of Market during the forecast period (2021-2027)?
• Which segments (product type/applications/end-user) were most attractive for investments in 2021? How these segments are expected to grow during the forecast period (2021-2027).
• Which manufacturer/vendor/players in the Oncolytic Virus Therapy Market was the market leader in 2020?
• Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.